Bayu Buana Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bayu Buana Tbk trades at Rp1,145 (market cap 399.14B, 17.9K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Bayu Buana Tbk is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (159.2K versus 17.9K). Which is the better fit depends on your goals.
| BAYU | DGNS | |
|---|---|---|
Market Cap | 399.14B | 310.75B |
Volume | 17.9K | 159.2K |
Lot | 179 | 1.59K |
Turnover | 20.33M | 34.72M |
Average Price | 1,135.56 | 218.06 |
Value | 20.33M | 34.72M |
Indicative Equilibrium Price | 1,145 | 220 |
Indicative Equilibrium Volume | 2 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bayu Buana Tbk (the Company), is domiciled in Jakarta, was established under Notarial Deed No. 22 of Didi Sudjadi, S.H., dated October 17, 1972.
Read more on BAYU →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →